Balchem (NASDAQ:BCPC) Trading Down 85.2% - Here's What Happened

Shares of Balchem Co. (NASDAQ:BCPC - Get Free Report) dropped 85.2% on Tuesday . The stock traded as low as $163.04 and last traded at $24.28. Approximately 111,229 shares changed hands during mid-day trading, a decline of 2% from the average daily volume of 114,079 shares. The stock had previously closed at $164.52.

Analyst Ratings Changes

BCPC has been the topic of several research reports. HC Wainwright reiterated a "buy" rating and set a $190.00 price target on shares of Balchem in a research report on Monday, February 24th. StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, Sidoti upgraded Balchem to a "hold" rating in a report on Tuesday, February 25th.

Balchem Trading Down 1.4 %

The business's 50-day moving average price is $165.26 and its two-hundred day moving average price is $169.24. The company has a market capitalization of $5.33 billion, a price-to-earnings ratio of 41.68, a P/E/G ratio of 4.41 and a beta of 0.63. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Research analysts predict that Balchem Co. will post 4.64 earnings per share for the current year.

Remove Ads

Institutional Trading of Balchem

Hedge funds and other institutional investors have recently bought and sold shares of the business. Mackenzie Financial Corp boosted its stake in Balchem by 2.2% in the fourth quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock valued at $626,000 after acquiring an additional 84 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of Balchem during the 4th quarter valued at about $3,246,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Balchem by 9.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 91,742 shares of the basic materials company's stock valued at $14,953,000 after buying an additional 8,091 shares in the last quarter. Voloridge Investment Management LLC lifted its stake in Balchem by 41.0% during the fourth quarter. Voloridge Investment Management LLC now owns 26,178 shares of the basic materials company's stock worth $4,267,000 after purchasing an additional 7,608 shares during the last quarter. Finally, Vident Advisory LLC lifted its position in Balchem by 6.0% in the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after buying an additional 80 shares during the last quarter. Institutional investors own 87.91% of the company's stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.